Hepatitis C

Hepatitis C is a deadly viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often exorbitant complications emerge as a result of damage to the liver. It is evaluates that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on growing improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be conceivably cured.

 

  • Recent Advances in Hepatitis C therapy
  • Prevention of HCV reinfection
  • HCV: Direct Acting Antiviral Era
  • Hepatitis C: Epidemiology
  • HCV Kinetic Models and Implications in Drug Development
  • Treatment options in patients who failed DAA regimens

Related Conference of Hepatitis C

July 08-09-2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
September 23-24, 2019

2nd World Summit on Liver Cirrhosis and Hepatitis

Tokyo, Japan
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia
October 23-24, 2019

World Congress on Pancreatic Cancer and Liver Diseases

| Tokyo, Japan
October 29-30, 2019

World conference on Digestive and Metabolic diseases

Berlin, Germany
November 18-19, 2019

20th World Congress on Gastroenterology

Rome, Italy
March 15-16, 2020

7th World Congress on Hepatitis & Liver Diseases

Osaka, Japan

Hepatitis C Conference Speakers

Recommended Sessions

Related Journals

Are you interested in